Establishing biomarkers for soft tissue sarcomas

AM Czarnecka, P Chmiel, P Błoński… - Expert Review of …, 2024 - Taylor & Francis
Introduction Soft tissue sarcomas (STS) are a rare and diverse group of tumors. Curative
options are limited to localized disease, with surgery being the mainstay. Advanced stages …

Genetic, epigenetic and transcriptome alterations in liposarcoma for target therapy selection

EA Lesovaya, TI Fetisov, BY Bokhyan, VP Maksimova… - Cancers, 2024 - mdpi.com
Simple Summary Liposarcoma is the most widespread soft-tissue sarcoma in adults. This
review summarizes the molecular genetics and epigenetics of the main liposarcoma …

Safety and efficacy of percutaneous cryoablation for recurrent or metastatic soft-tissue sarcoma in adult patients

K Pal, A Awad, S Yevich, JD Kuban, AL Tam… - American Journal of …, 2024 - ajronline.org
BACKGROUND. Treatment options are limited in patients with recurrent or metastatic
disease after initial treatment of soft-tissue sarcoma (STS) by surgical resection, radiation, or …

Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver

A Awad, K Pal, S Yevich, JD Kuban, A Tam… - Cancer, 2024 - Wiley Online Library
Purpose To evaluate outcomes following percutaneous image‐guided ablation of soft tissue
sarcoma metastases to the liver. Materials and Methods A single‐institution retrospective …

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes

RA Denu, RK Yang, AJ Lazar, SS Patel… - Clinical Cancer …, 2023 - aacrjournals.org
Purpose: Chondrosarcomas are the most common primary bone tumor in adults. Isocitrate
dehydrogenase 1 (IDH1) and IDH2 mutations are prevalent. We aimed to assess the clinico …

[HTML][HTML] Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications

C Parisi, M Tagliamento, L Belcaid, M Aldea… - The Journal of Liquid …, 2023 - Elsevier
Tumor derived biomarkers including circulating tumor DNA (ctDNA) and/or circulating
tumors cells (CTCs) may be detected and quantified through liquid biopsy (LB). ctDNA …

The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol

MA Banu, SM Raza, M Amini, S Seaman, F Rubino… - Neurosurgical …, 2024 - thejns.org
The role of systemic therapy in primary or advanced and metastatic chordoma has been
traditionally limited because of the inherent resistance to cytotoxic therapies and lack of …

TRKing sarcomas for precision medicine: Seek, and ye shall find!

JT Moyers, V Subbiah - Cancer, 2023 - Wiley Online Library
Plain language summary The way in which we treat different types of cancer has changed a
lot because of genome‐driven precision oncology. This approach uses information from a …

Reclassification of a spindle cell sarcoma after identification of a TFG‐ROS1 fusion: A case demonstrating the clinical benefit of next‐generation sequencing in …

JJ Lim, EY Chen, SK Schaub… - Molecular Genetics & …, 2024 - Wiley Online Library
Abstract Background Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal soft
tissue sarcomas that often present diagnostic challenges due to their wide and varied …

Machine learning-based analysis of genomic and transcriptomic data unveils sarcoma clusters with superlative prognostic and predictive value

M Esperanca-Martins, H Vasques, MS Ravasqueira… - medRxiv, 2025 - medrxiv.org
Soft tissue sarcomas (STS) histopathological classification system has several conceptual
caveats, impacting prognostication and treatment. The clinical and molecular–based tools …